SE0102843L - Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod - Google Patents

Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod

Info

Publication number
SE0102843L
SE0102843L SE0102843A SE0102843A SE0102843L SE 0102843 L SE0102843 L SE 0102843L SE 0102843 A SE0102843 A SE 0102843A SE 0102843 A SE0102843 A SE 0102843A SE 0102843 L SE0102843 L SE 0102843L
Authority
SE
Sweden
Prior art keywords
iodate
pharmaceutical composition
oral pharmaceutical
composition containing
containing iodide
Prior art date
Application number
SE0102843A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE0102843D0 (sv
Inventor
Yongjun Duan
Kirk Dinehart
John Hickey
Jack Kessler
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of SE0102843D0 publication Critical patent/SE0102843D0/xx
Publication of SE0102843L publication Critical patent/SE0102843L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0102843A 1999-02-26 2001-08-27 Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod SE0102843L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/258,062 US6248335B1 (en) 1997-10-29 1999-02-26 Stabilized oral pharmaceutical composition containing iodide and iodate and method
PCT/US2000/004411 WO2000050046A1 (en) 1999-02-26 2000-02-22 Stabilized oral pharmaceutical composition containing iodide and iodate and method

Publications (2)

Publication Number Publication Date
SE0102843D0 SE0102843D0 (sv) 2001-08-27
SE0102843L true SE0102843L (sv) 2001-10-26

Family

ID=22978944

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102843A SE0102843L (sv) 1999-02-26 2001-08-27 Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod

Country Status (19)

Country Link
US (1) US6248335B1 (de)
JP (1) JP2002537341A (de)
KR (1) KR100674324B1 (de)
CN (1) CN1344163A (de)
AT (1) AT413795B (de)
AU (1) AU778774B2 (de)
BR (1) BR0008509A (de)
CA (1) CA2366679C (de)
DE (1) DE10084290T1 (de)
DK (1) DK176595B1 (de)
ES (1) ES2226514B2 (de)
FI (1) FI20011703A7 (de)
GB (1) GB2364641B (de)
IL (1) IL144955A (de)
MX (1) MXPA01008550A (de)
NO (1) NO20014101L (de)
SE (1) SE0102843L (de)
WO (1) WO2000050046A1 (de)
ZA (1) ZA200106451B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7147873B2 (en) * 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
EP2007225A1 (de) * 2004-12-24 2008-12-31 Council Of Scientific & Industrial Research Verbessertes iodiertes salz und verfahren zu seiner herstellung
EP1838617B1 (de) * 2005-01-10 2013-07-31 Secretary, Department Of Atomic Energy Calciumkaliumhexacyanoferrat(ii), diese verbindung enthaltende prophylaktische mischung und verwendung davon zur dekorporation von radiocaesium bei patienten, die von kernstrahlung betroffen sind
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
ES2978927T3 (es) 2012-03-29 2024-09-23 Epion Therapeutics Inc Soluciones de tratamiento ocular, dispositivos de administración y métodos de aumento de la administración
EP2830554A1 (de) 2012-03-29 2015-02-04 CXL Ophthalmics, LLC Okulares vernetzungssystem und verfahren zum verschliessen von wunden in der augenhornhaut
US9566301B2 (en) 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
WO2015080984A1 (en) 2013-11-27 2015-06-04 BioPharmX, Inc. Solid oral dosage form for breast symptoms
AU2015213577B2 (en) * 2014-02-10 2019-02-14 Fred Hutchinson Cancer Center Halogen treatment of heart attack and ischemic injury
US20170304359A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
US11596648B2 (en) 2016-07-21 2023-03-07 I2Pure Corp. Emollient topical disinfectants
WO2018053335A1 (en) * 2016-09-16 2018-03-22 Iogen Llc Oral molecular iodine composition and method
CA3102792A1 (en) * 2018-06-08 2019-12-12 Faraday Pharmaceuticals, Inc. Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome
WO2022036280A1 (en) 2020-08-13 2022-02-17 I2Pure Corp. High molecular iodine concentration compositions, pharmaceutical formulations, preparation and uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486317A (en) * 1981-01-16 1984-12-04 E. I. Du Pont De Nemours And Company Stabilization of thickened aqueous fluids
RO85156B1 (ro) * 1983-05-27 1984-11-30 Institutul De Stiinte Biologice Comprimate-reactiv pentru determinarea alfa-anilazei si procedeu de obtinere a acestora
CN1036629C (zh) * 1991-03-16 1997-12-10 李克亮 动物促长剂
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
CA2317587A1 (en) * 1998-01-06 1999-07-15 Fujisawa Pharmaceutical Co., Ltd. Solid iodophor preparations and process for producing the same
US5985340A (en) * 1998-01-19 1999-11-16 Bolentica, Inc. Method for preparing iodine supplement for animal feeds

Also Published As

Publication number Publication date
CA2366679C (en) 2007-05-01
JP2002537341A (ja) 2002-11-05
ES2226514B2 (es) 2007-02-16
GB2364641A (en) 2002-02-06
CA2366679A1 (en) 2000-08-31
DK200101258A (da) 2001-10-26
SE0102843D0 (sv) 2001-08-27
FI20011703A0 (fi) 2001-08-24
DK176595B1 (da) 2008-10-20
AU3371300A (en) 2000-09-14
WO2000050046A1 (en) 2000-08-31
AU778774B2 (en) 2004-12-23
FI20011703L (fi) 2001-10-16
BR0008509A (pt) 2002-02-05
US6248335B1 (en) 2001-06-19
WO2000050046A8 (en) 2003-11-27
ES2226514A1 (es) 2005-03-16
KR20010103014A (ko) 2001-11-17
MXPA01008550A (es) 2003-08-19
IL144955A0 (en) 2002-06-30
NO20014101D0 (no) 2001-08-23
GB0122808D0 (en) 2001-11-14
GB2364641B (en) 2004-06-30
KR100674324B1 (ko) 2007-01-24
FI20011703A7 (fi) 2001-10-16
DE10084290T1 (de) 2003-04-03
CN1344163A (zh) 2002-04-10
ZA200106451B (en) 2002-08-06
NO20014101L (no) 2001-10-12
ATA90122000A (de) 2005-10-15
AT413795B (de) 2006-06-15
IL144955A (en) 2006-12-31

Similar Documents

Publication Publication Date Title
SE0102843L (sv) Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
EP1100522A4 (de) Verabreichung aktiver wirkstoffe über die lunge
FI960032L (fi) Farmaseuttisia koostumuksia vaikeasti liukenevia aktiiviaineita varten
DE59707812D1 (de) Opioidantagonisthaltige galenische formulierung
IL153297A0 (en) Compounds and compositions for delivering active agents
BR9810495A (pt) Composição farmacêutica
PL347671A1 (en) Compounds and compositions for delivering active agents
CY1113609T1 (el) ΔΙΑΛΥΤΟΤΗΤΑ ΙFΝ-ΒΗΤΑ-1b ΣΕ ΔΙΑΛΥΜΑΤΑ ΧΛΩΡΙΟΥΧΟΥ ΝΑΤΡΙΟΥ
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
EP1246792A4 (de) Verbindungen und zusammensetzung zur abgabe von wirkstoffen
DE60024414D1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
IT1302682B1 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
IT1312115B1 (it) Composti amorfi e relative composizioni farmaceutiche
ATE357928T1 (de) Pharmazeutische zusammensetzung für thrombinpeptidderivaten
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
SE9902742D0 (sv) New pharmaceutical formultion
ATE208627T1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen

Legal Events

Date Code Title Description
NAV Patent application has lapsed